SERUM-LIPIDS IN NORMOLIPIDEMICS AND HYPERLIPIDEMICS AFTER METHYLDOPA AND PROPRANOLOL

被引：20

作者：

DUJOVNE, CA

DECOURSEY, S

KREHBIEL, P

JACKSON, B

CHERNOFF, S

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 02期

关键词：

D O I：

10.1038/clpt.1984.156

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：157 / 162

页数：6

相关论文

共 18 条

[1] ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2] NEGATIVE EFFECTS OF DIURETIC DRUGS ON METABOLIC RISK-FACTORS FOR CORONARY HEART-DISEASE - POSSIBLE ALTERNATIVE DRUG THERAPIES
AMES, RP
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (04) : 632 - 638
[3] BACHORIK PS, 1982, CLIN CHEM, V28, P1375
[4] PROPRANOLOL AND HYPERTRIGLYCERIDEMIA
BARBORIA.JJ
FRIEDBER.HD
[J]. ATHEROSCLEROSIS, 1973, 17 (01) : 31 - 35
[5] BUCOLO G, 1973, CLIN CHEM, V19, P476
[6] CARLSON LA, 1972, LANCET, V1, P865
[7] DUJOVNE CA, 1979, AM J MED SCI, V277, P244
[8] EFFECT OF L-PROPRANOLOL ON THE BINDING, INTERNALIZATION AND DEGRADATION OF I-125 LOW-DENSITY LIPOPROTEINS BY HUMAN-SKIN FIBROBLASTS
GHISELLI, G
BERNINI, F
MUSANTI, R
FUMAGALLI, R
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 103 (03) : 1060 - 1068
[9] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
GORDON, T
CASTELLI, WP
HJORTLAND, MC
KANNEL, WB
DAWBER, TR
[J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714
[10] GROVE TH, 1979, CLIN CHEM, V25, P560